Main Sector
Biotechnology - Therapeutics and Diagnostics
Subsector
Small molecules
Indications
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Musculoskeletal system and connective tissue / Orthopedics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Social circumstances / substance related disorders / addiction
Products
In development: 12
On the market: 4
Description
Axsome Therapeutics focuses on developing and commercializing innovative therapies for central nervous system (CNS) disorders with high unmet medical needs. The company's commercial portfolio features FDA-approved treatments like Auvelity for major depressive disorder, Sunosi for excessive daytime sleepiness, and Symbravo for migraine. The company's pipeline continues to advance clinical-stage candidates, including AXS-05, AXS-12, and AXS-14, which target a broad range of indications such as...
